Efficacy of LAVITA home monitoring system in patients with heart failure

Efficacy of LAVITA home monitoring system in patients with heart failure - LAVITA pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045259

Enrollment

Registered

2021-08-25

Start date

2021-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Able to access the LAVITA-web application via their smartphone or PC Have wi-fi network at their home Diagnosed with heart failure Able to input their daily biometric data via the application

Exclusion criteria

Exclusion criteria: Unable to use a smartphone daily No wi-fi network Unable to use the LAVITA-web application

Design outcomes

Primary

Measure	Time frame
Measurement rates of body weight, blood pressure, pulse rate, SpO2, and activity levels from 9 to 12 weeks.	—

Secondary

Measure	Time frame
Differences of following variables from baseline to 12 weeks (3 months). 1) Bodyweight 2) Vital signs (blood pressure, pulse rate) 3) SpO2 4) activity level (steps) 5) NT-proBNP 6) CTR by CXR 7) LVEF, LVDd/Ds, E/e' 8) Heart failure readmission 9) All-cause death	—

Countries

Japan

Contacts

Public ContactAkihiro Nomura

Kanazawa University Innovative Clinical Research Center

anomura@med.kanazawa-u.ac.jp076-265-2049

Outcome results